Fortis Healthcare Limited — Investor Meet, 11-08-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Fortis Healthcare reported a strong Q1 FY26. Consolidated revenue grew 16.6% to INR 2,167 Cr, with hospital revenue up 18.6% to INR 1,838 Cr. Consolidated operating EBITDA jumped 43.2% to INR 491 Cr, achieving a 22.6% margin. Hospital ARPOB increased 10.2% to INR 2.65 Cr/annum, driven by specialty mix (oncology +28%, robotic surgeries +75%) and 69% occupancy.

Diagnostics revenue (adjusted for one-offs) grew 9.3% with margins at 23%. Agilus plans to re-leverage the SRL brand. The company expanded its network by acquiring Shrimann Hospital (228 beds) and signing an O&M agreement for Gleneagles' 700 beds, bringing total beds to 5,700+. Management is confident, projecting continued margin improvement and adding ~900 beds this FY, with 50% operational.